Table 3 also summarizes the predictive performance for miR-122, HMGB1, K18, and GLDH quantified from the first presentation sample to reflect ALI in patients admitted to the hospital emergency room later than 8 hours following overdose (n = 62).
Firstly, diffractograms show the disturbance introduced in the presentation of the sample.
We demonstrated markedly reduced ADAMTS13 antigen levels in all presentation samples, median 6% normal (range 0 47%), with 84/91 patients having < 25%ADAMTS13antigenen.
Regarding the number of samples considered in each analysis, we are sorry for the confusion of the presentation of sample size in Figure 3 figure supplement 1 and Figure 4. To clarify the samples used in our study, we present our data in Author response image 10.
The stage design strength ratio, as obtained from the three outlined flexible pavement design methods, will be investigated using variable design input parameters with results provided in the sample presentation section.
ADAMTS13 antigen levels were lower in presentation samples of patients who died (median 1.0% vs. 5.5%).
In 91 TTP presentation samples (one sample was lost to analysis due to insufficient sample size), ADAMTS13 concentrations were significantly lower [median 58 ng/ml (6% normal); range 0 450 ng/ml (0%47%%)] than in 67 normal volunteers [median 951 ng/ml (range 515 1829 ng/ml) p < 0.0001] (Fig. 5A).
As Sample 2 constitutes a group of participants in the same age range as that of Sample 1 in 2007, the presentation of this newest sample can be seen as our way to partly address this problem.
These samples were included in the presentation of the population distribution of follicular fluid organochorine concentrations.
Mentions various personalities used in the presentation.
